P18.17.B EFFECTIVENESS OF DABRAFENIB-TRAMETINIB AND LAROTRECTINIB IN ADULT RECURRENT GLIOBLASTOMA PATIENTS: A REAL-LIFE COHORT ANALYSIS FROM 3 ITALIAN CENTERS
Sign Up to like & getrecommendations! Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae144.333
Abstract: Although less than 5% and 1.5% of glioblastomas (GBM) exhibit the BRAFV600E mutation and NRTK fusion, respectively, these cases are significant because some of these patients (pts) may respond well to BRAF/MEK and NTRK inhibitors.… read more here.
Keywords: oncology; trametinib larotrectinib; target therapy; dabrafenib trametinib ... See more keywords